.png
)
4th June, 2026 Drugs Controller General of India (DCGI), issued a formal circular directing all drug manufacturers and all stakeholders to ensure they have a working pharmacovigilance (PV) system in place — one that is fully compliant with the Drugs…
When a new drug enters the market, it brings with it both hope and uncertainty. Clinical trials, despite their scientific rigor, are limited in scope — they can’t predict how a drug will behave in real-world conditions, across varied patient…
In the pharmaceutical world, Adverse Drug Reactions (ADRs) are not just unfortunate events — they’re regulatory red flags, patient safety threats, and potential business disasters. Why is this so critical? Because a single overlooked ADR can lead to product…
Regulations in the pharmaceutical sector are dynamic, evolving to keep pace with new products and technologies. The Central Drugs Standard Control Organization (CDSCO), Government of India, continually updates its rules to ensure drug quality, safety, and efficacy. A significant development…